Assertion: ceftriaxone | /r/HasProperty | contraindicated
Facets:
value: in neonates
type: LOCATION
value: in newborns
type: LOCATION
value: up to age
type: OTHER
Source sentences:
text: Ceftriaxone is contraindicated in patients with known hypersensitivity to Ceftriaxone, any of its excipients or to any other cephalosporin.
text: Premature neonates: Ceftriaxone is contraindicated in premature neonates up to a postmenstrual age of 41 weeks (gestational age + chronological age).
text: Ceftriaxone is contraindicated in neonates (≤ 28 days) if they require (or are expected to require) treatment with calcium‑containing IV solutions, including continuous calcium-containing infusions such as parenteral nutrition because of the risk of precipitation of Ceftriaxone‑calcium (see CLINICAL PHARMACOLOGY, WARNINGS and DOSAGE AND ADMINISTRATION).
text: Ceftriaxone is contraindicated in premature neonates (see CONTRAINDICATIONS).
text: Ceftriaxone is contraindicated in neonates (≤28 days) if they require (or are expected to require) treatment with calcium‑containing IV solutions, including continuous calcium‑containing infusions such as parenteral nutrition because of the risk of precipitation of Ceftriaxone-calcium (see CONTRAINDICATIONS).
text: Ceftriaxone is contraindicated in:
text: Ceftriaxone is contraindicated in:
text: Ceftriaxone is contraindicated in:
text: We also advised that ceftriaxone is contraindicated in newborns who need calcium treatment because of a risk of precipitation of ceftriaxone–calcium salt.
text: Advice for healthcare professionals shows that: ceftriaxone is contraindicated in: premature newborns up to a corrected age of 41 weeks (weeks of gestation+weeks of life) full-term newborns up to age 28 days who: need treatment with calcium-containing solutions (including TPN solutions), because of a risk of precipitation of ceftriaxone–calcium salt have jaundice or who are hypoalbuminaemic or acidotic, because these are conditions in which bilirubin binding is likely to be impaired